Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Plume, a real world asset (RWA)-focused blockchain project, has debuted its Nest yield vaults directly on Solana, giving the network’s users native access to institutional-grade real-world assets for ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

You can stop looking for glitches in the Matrix—it’s finally been proven that our universe is not merely a simulation running on some powerful alien civilization’s supercomputer. An international team ...

MARSHALLTOWN, Iowa--(BUSINESS WIRE)--The Integration Group (TIG), a portfolio company of Maxwell Street Capital Partners (Maxwell Street), has acquired Matrix Management (Matrix), a Chicago-based ...

Is this real life? Is this just fantasy? A growing number of scientists are suggesting that the idea that we are all living in a simulation may not be completely far-fetched. Simulation theory is the ...